期刊文献+

散发性阿尔茨海默病患者脑源性神经营养因子基因Val66Met多态性与载脂蛋白基因多态性关联性分析

Analysis of the Interaction of the Val66Met Polymorphisms of Brain-derived Neurotrophic Factor Gene and APOE Gene in Sporadic Alzheimer's Disease
下载PDF
导出
摘要 目的探讨脑源性神经营养因子(BDNF)基因Val66Met、载脂蛋白E(APOE)基因多态性在散发性阿尔茨海默病(sporadic Alzheimer disease,sAD)发病机制中的作用。方法应用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)方法,检测80例sAD患者和86例健康人中BDNF基因Val66Met和APOE基因多态性分布,并通过比值比(OR)对这两种基因与AD之间进行关联性分析。结果BDNF基因Val66Met多态性与sAD的发病风险显著相关;Met/Met基因型与Val等位基因携带者的OR=2.87,95%CI=1.31-6.28。SAD患者与APOE基因的ε4等位基因正关联,APOEε4与非ε4的OR=3.87,95%CI=1.91-7.88。在APOEε4中携带BDNF Met等位基因的OR=3.95,95%CI=1.40-11.16。结论BDNF基因Val66Met多态性可能是sAD发病的遗传危险因素,BDNF基因Val66Met多态性与APOE基因多态性之间有协同作用,APOEε4等位基因与BDNF Met等位基因同时存在时,患AD的危险性显著提高。 Objective To explore the association between BDNF Val66Met and APOE gene polymorphisrns and sporadic Alzheimer's disease (sAD). Methods The polymorphisrns of BDNF Val66Met and APOE gene were determined in 80 sAD patients and 86 normal controls by PCR - RFLP method. Results The polymorphisms of Val66Met was significantly associa ted with sAD risk. The odds ratio for sAD associated with the Met/Met genotype VS Val - carriers was 2.87 (95%CI= 1.31 -6.28), while that of 4 vsnon- 4 in APOE gene was 3.87 (95%CI= 1.91 - 7.88). The odds ratio for APOεE and BDNF Met- carriers was 3.95 (95 % CI = 1.40 - 11.16). Conclusion BDNF Val66Met polymorohism may be an independent genetic risk factor for sAD in Chinese, and the onset of sAD is associated with the interaction of the polymorphisms of BDNF Val66Met and APOE gene.
出处 《黑龙江医学》 2009年第10期724-726,共3页 Heilongjiang Medical Journal
关键词 阿尔茨海默病 脑源性神经营养因子 载脂蛋白E 多态性 限制性片段长度 Alzheimer disease Brain-derived neurotrophic factor Apolipoproteins E Polymorphism Restriction fragment length
  • 相关文献

参考文献8

  • 1Murer MG, Boissiere F, Yan Q, et al . An immunohistochemical study of the distribution of brain - derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer' s disease [J]. Neuroscience, 1999, 88:1 015 - 1 032.
  • 2Snider WD. Functions of the neurotrophins during nervous system development: what the knockouts are teaching us[J]. Cell, 1994, 77:627 - 638.
  • 3Phillips HS, Hains JM, Armanini M, et al . BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer' s disease[J]. Neuron, 1991, 7:695 - 702.
  • 4Hock C, Heese K, Hulette C, et al . Region - specific neumtrophin imbalances in Mzheimer disease: Decreased levels of brain - derived neumtmphic factor and increased levels of nerve growth factor in hippocampus and cortical areas[J].Arch Neural, 2000, 57 : 846 - 851.
  • 5Egan MF, Kojima M, Callicot JH, et al . The BDNF and human memory and Hippocampal function[J]. Cell, 2003, 112:257 - 269.
  • 6Hariri AR, Goldberg TE, Mattay VS, et al . Brain-derived neurotrophic factor Va166Met polymorphism affects human memory- related hippocampal activ. ity and predicts memory performance [J]. J Neurosci, 2003, 23 : 6 690 - 6 694.
  • 7Tsai SJ, Hong CJ, Liu HC, et al . The Brain -Derived Neurotrophic Factor Gene as a Possible Susceptibility Candidate for Alzheimer' s Disease in a Chinese Population[J].Dement Geriatr Cogn Disord, 2006, 21 : 139 - 143.
  • 8Lu B, Gottschalk W. Modulation of hippocampal synaptic transmission and plasticity by neurotrophins [J].Prog Brain Res, 2000, 128:231 -241.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部